Related Experiment Video
Updated: Jun 23, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Mechanisms underlying pleiotropic effects of statins
Chandrasekar Palaniswamy1, Dhana Rekha Selvaraj, Thiruvenkadam Selvaraj
1New York Medical College, NY 10595, USA. drpchandrasekar@gmail.com
American Journal of Therapeutics
|May 20, 2009
Summary
Statins effectively lower lipids and prevent cardiovascular events. Emerging research reveals significant benefits beyond lipid reduction, highlighting their pleiotropic effects.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
- Biochemistry
Background:
- Statins are primary hypolipidemic drugs with proven efficacy in cardiovascular event prevention.
- Their benefits were initially attributed solely to lipid reduction.
- Widespread statin use has revealed effects beyond lipid modulation.
Purpose of the Study:
- To review the non-lipid-lowering (pleiotropic) effects of statins.
- To describe the mechanisms and pathways underlying these pleiotropic actions.
Main Methods:
- Literature review of clinical trials and meta-analyses.
- Analysis of studies investigating statin mechanisms of action.
Main Results:
- Statins demonstrate significant cardiovascular benefits, independent of lipid-lowering.
- Pleiotropic effects contribute substantially to overall therapeutic outcomes.
- Various molecular pathways mediate these additional benefits.
Conclusions:
- Statin-mediated pleiotropic effects are crucial for cardiovascular protection.
- Understanding these mechanisms can optimize therapeutic strategies.
- Further research into pleiotropic actions is warranted.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...